Earlier this year, in April, NASA announced development of Ventilator Intervention Technology Accessible Locally (VITAL), a ventilator designed specifically with COVID-19 in mind. Existing ventilators have more general use cases, but are more expensive and more difficult to build. Currently, 28 manufacturers are licensed to build VITAL, with models variably either pneumatic or using compressed air. In August, one such manufacturer, Russer, has gained approval for its pneumatic model from Anvisa, which is Brazil’s equivalent of the FDA. Nonprofit research organization CIMATEC in Brazil helped develop the Brazilian model. Leone Andrade, the Director of CIMATEC, says that VITAL can also help boost Brazilian industry in addition to helping combat the pandemic.